Francesca Panimolle

Francesca Panimolle

Auto-generated profile, based on publicly available information

Francesca Panimolle

Center of Rare Diseases, Section of Medical Pathophysiology, Department of Experimental Medicine, Sapienza University of Rome, Roma, Italy

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
TFTiziana Filardi
Tiziana Filardi
FPFrancesca Panimolle
Francesca Panimolle
CCClara Crescioli
Clara Crescioli
ALAndrea Lenzi
Andrea Lenzi
SMSusanna Morano
Susanna Morano
Gestational diabetes mellitus (GDM) is defined as “glucose intolerance that is first diagnosed during pregnancy”. Mothers with GDM and their infants may experience both short and long term complications. Dietary intervention is the first therapeutic strategy. If good glycaemic control is not achieved, insulin therapy is recommended. There is no consensus on which nutritional approach should be used in GDM. In the last few years, there has been growing evidence of the benefits of a low glycaemic index (LGI) diet on diabetes and cardiovascular disease. The effect of a LGI diet on GDM incidence has been investigated as well. Several studies observed a lower incidence of GDM in LGI diet arms, without adverse maternal and fetal outcomes. The main positive effect of the LGI diet was the reduction of 2-h post-prandial glucose (PPG). Several studies have also evaluated the effect of the LGI diet in GDM treatment. Overall, the LGI diet might have beneficial effects on certain outcomes, such as 2-h PPG, fasting plasma glucose and lipid profile in patients with GDM. Indeed, most studies observed a significant reduction in insulin requirement. Overall, according to current evidence, the LGI nutritional approach is safe and it might therefore be considered in clinical care for GDM.

3 May 2015 in Endocrine
Verified
Journal Article
Closed access
PDF file
FPFrancesca Panimolle
Francesca Panimolle
CTClaudio Tiberti
Claudio Tiberti
SGSimona Granato
Simona Granato
ASAntonella Semeraro
Antonella Semeraro
DGDaniele Gianfrilli
Daniele Gianfrilli
ARAntonio Radicioni
Antonio Radicioni

12 May 2021 in Clinical and Experimental Immunology
Verified
Journal Article
Closed access
PDF file
FPFrancesca Panimolle
Francesca Panimolle
CTClaudio Tiberti
Claudio Tiberti
MSMatteo Spaziani
Matteo Spaziani
GRGloria Riitano
Gloria Riitano
GLGiuseppe Lucania
Giuseppe Lucania
ARAntonio F. Radicioni
Antonio F. Radicioni

3 May 2020 in Scandinavian Journal of Gastroenterology
Verified
Journal Article
Closed access
CTClaudio Tiberti
Claudio Tiberti
FPFrancesca Panimolle
Francesca Panimolle
RBRaffaele Borghini
Raffaele Borghini
MMMonica Montuori
Monica Montuori
CTChiara Maria Trovato
Chiara Maria Trovato
APAntonio Picarelli
Antonio Picarelli
Background: No data are available on the frequency of organ-specific humoral autoimmunity at diagnosis of adult celiac disease (CD). Aim: To evaluate the humoral immunoreactivities specific of type 1 diabetes (T1D), thyroid (THD), atrophic-gastritis (AG) and Addison’s (AD) diseases in 92 adult CD patients at diagnosis and 237 adult healthy subjects (CTRL). Methods: T1D, THD and AD specific autoantibodies were analyzed by radioimmunoprecipitation assays. AG autoantibodies were detected by enzyme-linked immunosorbent assay. Results: Of 92 CD patients, 31.5% were positive for at least one of the organ-specific autoantibodies investigated (p < .0001 vs CTRL). Thyroid, diabetes, gastric and adrenal-autoantibodies, that increase with age at diagnosis, were detected in 12.0%, 10.9%, 10.9%, 2.2% of CD patients, respectively. Gastric- and diabetes- rather than thyroid- and adrenal-autoimmunity seem to be specifically related to presence of CD. Conclusions: One third of adult CD patients at diagnosis is target of at least one organ-specific autoantibody. A systematic organ-specific autoantibody screening in these patients might be of value to promptly identify, prevent or treat the relative diseases.

20 August 2018 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Closed access
CTClaudio Tiberti
Claudio Tiberti
SZSimona Zampetti
Simona Zampetti
DCDanila Capoccia
Danila Capoccia
GCGiuseppe Campagna
Giuseppe Campagna
FLFederica Lucantoni
Federica Lucantoni
RBRaffaella Buzzetti
Raffaella Buzzetti

19 May 2018 in Autoimmunity
Verified
Journal Article
Closed access
FPFrancesca Panimolle
Francesca Panimolle
CTClaudio Tiberti
Claudio Tiberti
SGSimona Granato
Simona Granato
AAAntonella Anzuini
Antonella Anzuini
CPCarlotta Pozza
Carlotta Pozza
ARAntonio F. Radicioni
Antonio F. Radicioni
Objective: In literature, the importance of X-linked gene dosage as a contributing factor for autoimmune diseases is generally assumed. However, little information is available on the frequency of humoral endocrine organ-specific autoimmunity in X-chromosome aneuploidies. In our preliminary study, we investigated the endocrine organ-specific humoral autoimmunity relative to four different organ-specific autoimmune diseases in a group of adult 47,XXY KS patients and in adults 46,XY control males (type 1 diabetes, T1DM; Addison’s disease, AD; Hashimoto thyroiditis, HT; autoimmune chronic atrophic gastritis, AG). The aim of the present study is to evaluate the frequency of autoantibodies (Abs) specific for T1DM, AD, HT, and AG in rarer higher grade X-chromosome aneuploidies (HGA) and in 47,XXY children. Design and methods: Samples from 192 Caucasian patients with an X-chromosome aneuploidy (176 patients (55 children, 121 adults) with 47,XXY karyotype (KS patients) and 16 HGA patients (eight children, eight adults)) recruited from Sapienza, University of Rome (2007–2017) were tested for Abs specific for T1DM (insulin-Abs, GAD-Abs, IA-2-Abs, Znt8-Abs), HT (TPO-Abs), AD (21-OH-Abs), and AG (APC-Abs). The results were compared to those found in 213 46,XY control subjects (96 children, 117 adults). Results: Altogether humoral organ-specific immunoreactivity was found in 13% of KS and HGA patients, with a significantly higher frequency than in the controls (p=.008). Almost 19% of HGA patients were positive for at least one of the organ-specific Abs investigated compared to 12.5% of KS patients. The frequency of the overall immunoreactivity was higher in KS children than in KS adults. The frequency of diabetes-specific Abs was significantly higher in the patient cohort than in controls (p=.005). Thyroid- and gastric-specific autoimmunity was also found in KS and HGA patients, while adrenal-specific immunoreactivity was rare. Conclusions: These results suggest for the first time that the risk of endocrine organ-specific humoral autoimmunity progressively increases with the severity of X-chromosome polisomy. The screening for diabetes-, thyroid-, and gastric-specific autoimmunity should be considered in clinical practice for identifying rare and classic X-chromosome aneuploid patients at risk of developing organ-specific autoimmune diseases.